Evelyn Fox Keller Objects To Editor's Title

I was shocked and dismayed at the headline, or title, attached to my article in the October 15 issue of The Scientist [page 15]. The title not only was different from my original title--"Issues of Sex and Gender in the Pursuit of Science"--but entirely contrary to the meaning of my article, as it was, indeed, to all my efforts over the past decade. If there is a single point on which all feminist scholarship over the past decade has converged, it is the importance of recognizing the social con

Written byEvelyn Fox Keller
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

If there is a single point on which all feminist scholarship over the past decade has converged, it is the importance of recognizing the social construction of gender, and the deeply oppressive consequences of assuming that men and women are, in Simone de Beauvoir's words, "born rather than made." All of my work on gender and science proceeds from this basic recognition. My endeavor has been to call attention to the ways in which the social construction of a binary opposition between "masculine" and "feminine" has influenced the social construction of science. I argue that it is only by recognizing the social character of the construction of both gender and science that we can realize the emancipatory value--for men, for women, and for science--of transcending that opposition. The first step, of course, is to abandon the myth that the opposition between "masculine" and "feminine" is somehow "natural," and therefore fixed. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies